Davis Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
ATO
QP
Davis Capital Management's MRK Position: Q2 2026 in Review
Davis Capital Management increased its Merck (MRK) stake by 176% in Q2 2026, buying an estimated $4.33K and bringing the position to 58 shares worth $7.45K. The position accounts for ﹤0.01% of the portfolio, ranked #288.
Davis Capital Management first reported a position in MRK in Q1 2020 and has held it in 12 quarters since. The position peaked at $330K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Davis Capital Management held 58 shares of Merck worth $7.45K as of Q2 2026.
- Davis Capital Management bought 37 Merck shares in Q2 2026, an estimated $4.33K.
- Merck made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #288 holding.
- Davis Capital Management first reported a position in Merck in Q1 2020 and has held it in 12 quarters since.
- Davis Capital Management's Merck position peaked at $330K in Q1 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.